These findings are consistent with the hypothesis that PALB2-mutated BCs may be associated with high mutational load (44) and that the DNA repair genes inactivation may give rise to BC specific immune-phenotype, that could be leveraged with checkpoint blockade (45). This evidence concerns the gene PALB2 and breast cancer.